Tarantelli C, Wald D, Munz N, Spriano F, et al. Targeting CD19-positive lymphomas with the antibodydrug conjugate loncastuximab tesirine: preclinical evidence of activity as a single agent and in combination therapy. Haematologica 2024;109:3314-3326.
PMID: 38721745